C12N 2770/24334
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2770/24334 (Use of virus or viral component as vaccine) appears on 102 US grants and 125 published applications in this corpus.
Search patents in C12N- Granted patents
- 102
- Published applications
- 125
- Assignees
- 83
- Inventors
- 259
- Latest grant
- 13 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 4 | 0 |
| 2002 | 4 | 3 |
| 2003 | 3 | 4 |
| 2004 | 1 | 3 |
| 2005 | 4 | 5 |
| 2006 | 2 | 2 |
| 2007 | 0 | 5 |
| 2008 | 6 | 6 |
| 2009 | 5 | 11 |
| 2010 | 3 | 6 |
| 2011 | 2 | 7 |
| 2012 | 2 | 6 |
| 2013 | 5 | 6 |
| 2014 | 4 | 14 |
| 2015 | 1 | 2 |
| 2016 | 10 | 8 |
| 2017 | 9 | 7 |
| 2018 | 6 | 5 |
| 2019 | 6 | 3 |
| 2020 | 3 | 2 |
| 2021 | 3 | 5 |
| 2022 | 4 | 2 |
| 2023 | 0 | 3 |
| 2024 | 2 | 6 |
| 2025 | 3 | 3 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Adjuvant compositions13 Jan 2026US 12,521,433 B2Zoetis Services LLC
- Optimized host/vector system for producing protective mono-and multivalent subunit vaccines on the basis of the yeast Kluyveromyces lactis18 Nov 2025US 12,473,562 B2Verovaccines GmbH
- Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex13 May 2025US 12,296,003 B2Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
- Vaccine delivery method7 Jan 2025US 12,186,390 B2University of Georgia Research Foundation, Inc.
- Optimized host/vector system for producing protective mono- and multivalent subunit vaccines on the basis of the yeast Kluyveromyces lactis20 Feb 2024US 11,905,517 B2Verovaccines GmbH
- Oral vaccine20 Aug 2026US 2026/0240985 A1WestfäLische Wilhelms-UniversitäT MüNster
- Bovine viral diarrhea virus immunogenic compositions and methods of use thereof23 Oct 2025US 2025/0325645 A1Kansas State University Research Foundation
- Immunostimulatory preparation and cosmetic, food, feed additive, and quasi-pharmaceutical product containing the immunostimulatory preparation18 Sep 2025US 2025/0288663 A1Japan Eco-Science Co., Ltd.
- Recombinant classical swine fever virus e2 protein with b/c domain swapping17 Jul 2025US 2025/0230194 A1Boehringer Ingelheim Vetmedica (China) Co., Ltd.
- Novel Adjuvant Compositions31 Oct 2024US 2024/0358825 A1Zoetis Services LLC
Most cited
By later US patents
- Modified live BRSV vaccine77US 5,733,555 AAmerican Home Products Corporation · 1998
- Microfluidized oil-in-water emulsions and vaccine compositions41US 7,122,191 B2Pfizer Inc. · 2006
- Protein expression in baculovirus vector expression systems39US 6,555,346 B1Bayer Aktiengesellschaft · 2003
- Recombinant herpesvirus of turkeys comprising a foreign DNA inserted into a non-essential region of the herpesvirus of turkeys genome34US 6,121,043 ASyntro Corporation · 2000
- Polynucleotide formula against porcine reproductive and respiratory pathologies31US 6,207,165 B1Merial Limited · 2001